Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

The 9th annual Lafora science symposium: a rare epilepsy community makes progress towards clinical readiness

  • Meredith I. Williams
  • , Katherine J. Donohue
  • , Pascual Sanz
  • , Souad Messahel
  • , Jose M. Serratosa
  • , Jordi Duran
  • , Roberto Michelucci
  • , Lorenzo Muccioli
  • , Antonio Delgado-Escueta
  • , Viet Huong V. Nguyen
  • , Berge A. Minassian
  • , Matthew S. Gentry*
  • *Autor/a de correspondencia de este trabajo

Producción científica: Artículo en revista indizadaArtículorevisión exhaustiva

2 Citas (Scopus)

Resumen

Lafora disease (LD) is a fatal childhood progressive myoclonus epilepsy and glycogen storage disease that is caused by recessive mutations in either EPM2A or EPM2B. The hallmarks of LD are cytoplasmic, aberrant glycogen-like aggregates, called Lafora bodies (LBs), that drive disease progression. The 9th Annual Lafora Science Symposium was held in San Diego, California and brought together over 70 researchers, clinicians, academic trainees, and friends and family members of patients with LD and 80 attendees joined virtually. This symposium focused primarily on international collaborations for therapeutic development and biomarker identification and strategies for preparing the Lafora community for upcoming clinical trials.

Idioma originalInglés
Número de artículo110654
PublicaciónEpilepsy and Behavior
Volumen171
DOI
EstadoPublicada - oct 2025

Huella

Profundice en los temas de investigación de 'The 9th annual Lafora science symposium: a rare epilepsy community makes progress towards clinical readiness'. En conjunto forman una huella única.

Cómo citar